How AI helped build hreflang XML sitemaps at scale

Learn how iterative prompting, Python, and Google Colab helped turn a multilingual hreflang mapping project into a scalable ...
Yahoo Finance

NetApp’s Private AI Push With Iterate.ai And What It Means For Investors

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
NJ.com

Generac recalls generators from Costco, Home Depot, Lowe’s due to safety hazards: ‘Stop use immediately’

Hundreds of thousands of generators sold at retailers such as Costco, Lowe’s and Home Depot are being recalled due to serious safety hazards. According to warnings from the U.S. Consumer Product ...
USA Today

Nearly 150K Generac generators sold at Lowe's, Home Depot recalled

Nearly 150,000 generators sold at stores like Home Depot and Lowe’s are being recalled for posing a deadly fire hazard. According to an April 16 warning from the U.S. Consumer Product Safety ...
Reuters

Generate Biomedicines shares fall in weak Nasdaq debut for drug developer

Feb 27 (Reuters) - Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market ...
FierceBiotech

Behind Generate's 'feverish' race to raise $400M IPO while window remains open

Generate:Biomedicines has earmarked $300 million of its IPO funds to complete a pair of phase 3 asthma trials for its anti-TSLP antibody GB-0895. (Fabrice Cabaud/Stock/Getty Images Plus) ...
Bloomberg L.P.

Flagship-Backed Generate Biomedicines Raises $400 Million in IPO

Generate Biomedicines Inc. raised $400 million in an initial public offering, pricing its shares at the midpoint of the marketed range. The Somerville, Massachusetts-based drug developer sold 25 ...
Reuters

Flagship-backed Generate Biomedicines eyes $2.2 billion valuation in US IPO

Feb 23 (Reuters) - Drug developer Generate Biomedicines said on Monday it was targeting a valuation of up to $2.17 billion in its U.S. initial public offering, tapping into a resurgent biotech market ...
Seeking Alpha

Generate Biomedicines Begins IPO Push With Major Collaboration Deals

Generate Biomedicines, Inc. (GENB) has filed to raise public capital in an IPO to advance its pipeline of treatment candidates, according to an SEC filing. The company is developing treatments for ...
The Business Journals

Generate:Biomedicines eyes public markets as AI drug advances to late-stage trials

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Generate:Biomedicines raised ...
Bloomberg L.P.

Flagship-Backed Drug Firm Generate Biomedicines Files for US IPO

Generate Biomedicines Inc. filed for an initial public offering, joining a growing list of biotechnology firms to leap to public markets as investors embrace the sector. The Somerville, ...